Feed ZBH
ZB

Zimmer Biomet

ZBH · NYSE

$98.39 +1.92% (+$1.85)
1M -1.69%
Market Cap $17.9B
P/E Ratio 22.16x
Div. Yield 1.04%
ROE 6.36%

Bulios Fair Price

$66.81

32.1% downside

Current Price

$98.39

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ZBH is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
74 /100
Cheap
P/E 22.16x
EV/EBITDA 12.74x
P/S 2.10x
Growth
67 /100
Growing
EPS growth 47.78%
Rev. growth 5.85%
FCF growth 11.33%
Profitability
82 /100
Strong
Gross margin 69.87%
Net margin 9.48%
Op. margin 15.73%
Quality
30 /100
Poor
ROIC 5.51%
ROE 6.36%
ROA 3.54%
Debt
57 /100
Moderate
Debt/Equity 0.59x
Current ratio 1.69x
Int. coverage 4.25x
Stability
60 /100
Moderate
Beta 0.47x
Rev. volatility 1.78%
EPS volatility 206.86%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ZBH
Online

About the company

Zimmer Biomet Holdings, Inc. (ZBH) is an American company specializing in the manufacturing and distribution of medical devices and implants for orthopedics, traumatology, and other medical fields. The company provides a wide range of products, including artificial joints, bone implants, surgical instruments, and bioresorbable materials for the treatment of patients with orthopedic issues. Zimmer Biomet is a respected leader in the healthcare technology industry and contributes to advancements in treatment procedures and patient care. The company collaborates with medical professionals and research institutions to ensure the highest quality and safety of its products. Zimmer Biomet focuses on innovation and the development of new technologies that bring better outcomes and longer implant lifespan for doctors and patients. Its products are sought after and utilized in healthcare facilities worldwide. Shares of Zimmer Biomet Holdings, Inc. (ZBH) could represent an intriguing investment opportunity for those who believe in the growing demand for orthopedic medical devices and the benefits of modern healthcare technologies.

Sector

Healthcare

Industry

Medical - Devices

CEO

Ivan Tornos

Employees

17,000

Headquarters

Warsaw

Upcoming events

30 SEP

Ex-Dividend

Ex-dividend date

14d
30 OCT

Dividend Payment

Payment date

44d
04 NOV

Earnings

Upcoming earnings report

49d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.